Home > National Drug Code (NDC) > Topotecan Hydrochloride

Topotecan Hydrochloride - 25021-206-61 - (topotecan hydrochloride)

Alphabetical Index


Drug Information of Topotecan Hydrochloride

Product NDC: 25021-206
Proprietary Name: Topotecan Hydrochloride
Non Proprietary Name: topotecan hydrochloride
Active Ingredient(s): 4    mg/4mL & nbsp;   topotecan hydrochloride
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Topotecan Hydrochloride

Product NDC: 25021-206
Labeler Name: Sagent Pharmaceuticals
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA091284
Marketing Category: ANDA
Start Marketing Date: 20101128

Package Information of Topotecan Hydrochloride

Package NDC: 25021-206-61
Package Description: 5 CARTON in 1 BOX (25021-206-61) > 1 VIAL in 1 CARTON (25021-206-06) > 4 mL in 1 VIAL

NDC Information of Topotecan Hydrochloride

NDC Code 25021-206-61
Proprietary Name Topotecan Hydrochloride
Package Description 5 CARTON in 1 BOX (25021-206-61) > 1 VIAL in 1 CARTON (25021-206-06) > 4 mL in 1 VIAL
Product NDC 25021-206
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name topotecan hydrochloride
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20101128
Marketing Category Name ANDA
Labeler Name Sagent Pharmaceuticals
Substance Name TOPOTECAN HYDROCHLORIDE
Strength Number 4
Strength Unit mg/4mL
Pharmaceutical Classes Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]

Complete Information of Topotecan Hydrochloride


General Information